The Influence of Differentially Expressed Tissue-Type Plasminogen Activator in Experimental Autoimmune Encephalomyelitis: Implications for Multiple Sclerosis

• Lisa CM Dahl,

  Affiliation Molecular Neurotrauma and Haemostasis, Australian Centre for Blood Diseases, Central Clinical School, Monash University, Melbourne, VIC, 3004, Australia

  ⨯
• Zeyad Nasa,

  Affiliation Department of Immunology, Central Clinical School, Monash University, Melbourne, VIC, 3004, Australia

  ⨯
• JieYu Chung,

  Affiliation Department of Immunology, Central Clinical School, Monash University, Melbourne, VIC, 3004, Australia

  ⨯
• Be’eri Niego,

  Affiliation Molecular Neurotrauma and Haemostasis, Australian Centre for Blood Diseases, Central Clinical School, Monash University, Melbourne, VIC, 3004, Australia

  ⨯
• Volga Tarlac,

  Affiliation Van Cleef Roet Centre for Nervous Diseases, Central Clinical School, Monash University, Melbourne, VIC, 3004, Australia

  ⨯
• Heidi Ho,

  Affiliation Molecular Neurotrauma and Haemostasis, Australian Centre for Blood Diseases, Central Clinical School, Monash University, Melbourne, VIC, 3004, Australia

  ⨯
• Adam Galle,

  Affiliation Molecular Neurotrauma and Haemostasis, Australian Centre for Blood Diseases, Central Clinical School, Monash University, Melbourne, VIC, 3004, Australia

  ⨯
• Steven Petratos,

  Affiliation Department of Medicine, Central Clinical School, Monash University, Melbourne, 3004, Victoria, Australia

  ⨯
• Jae Young Lee,

  Affiliation Department of Medicine, Central Clinical School, Monash University, Melbourne, 3004, Victoria, Australia

  ⨯
• Frank Alderuccio,

  Affiliation Department of Immunology, Central Clinical School, Monash University, Melbourne, VIC, 3004, Australia

  ⨯
• Robert L. Medcalf

  * E-mail: robert.medcalf@monash.edu

  Affiliation Molecular Neurotrauma and Haemostasis, Australian Centre for Blood Diseases, Central Clinical School, Monash University, Melbourne, VIC, 3004, Australia

  ⨯